6 results
8-K
EX-99.1
IMNM
Immunome, Inc.
11 Jan 24
Regulation FD Disclosure
5:27pm
/journal.pone.0181598 Kaplan - Meier curves according to IL - 38 expression in patients with primary lung adenocarcinoma IL - 38 IHC Stain Intensity Low
8-K
EX-99.1
IMNM
Immunome, Inc.
15 Nov 23
Regulation FD Disclosure
6:03am
adenocarcinoma IL - 38 IHC Stain Intensity Low Medium High Checkpoint inhibition of IL - 38 presents a novel immunotherapy approach for cancer
16 IMMUNOME
425
EX-99.1
IMNM
Immunome, Inc.
5 Jul 23
Business combination disclosure
5:15pm
Stain Intensity Low Medium High Checkpoint inhibition of IL-38 presents a novel immunotherapy approach for cancer
MORPHIMMUNE + IMMUNOME 11 IMM20320
8-K
EX-99.1
IMNM
Immunome, Inc.
5 Jul 23
Morphimmune and Immunome Combined Corporate Presentation July 2023
5:12pm
Stain Intensity Low Medium High Checkpoint inhibition of IL-38 presents a novel immunotherapy approach for cancer
MORPHIMMUNE + IMMUNOME 11 IMM20320
425
EX-99.2
IMNM
Immunome, Inc.
29 Jun 23
Business combination disclosure
9:10am
IL-38 IHC Stain Intensity Low Medium High Checkpoint inhibition of IL-38 presents a novel immunotherapy approach for cancer
CONFIDENTIAL - DO
8-K
EX-99.2
s1dymhwhjp om8mnphj
29 Jun 23
Immunome and Morphimmune Announce Definitive Merger Agreement
9:08am
- Prev
- 1
- Next